Lowering of plasma phospholipid transfer protein activity by acute hyperglycaemia-induced hyperinsulinaemia in healthy men

Scandinavian Journal of Clinical and Laboratory Investigation

Volumn 57, Issue 2, 1997, Pages 147-157

  Van Tol, A ^a,c   Ligtenberg, J J M ^b   Riemens, S C ^b   Van Haeften, T W ^b   Reitsma, W D ^b   Dullaart, R P F ^b  

^a ERASMUS MC CANCER INSTITUTE   (Netherlands)

^b UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^c ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

Author keywords

CETP; cholesterylester transfer protein; hyperinsulinaemia; insulin resistance; phospholipid transfer protein; PLTP

Indexed keywords

CHOLESTEROL; CHOLESTEROL ESTER TRANSFER PROTEIN; GLUCOSE; INSULIN; LIPOPROTEIN; PHOSPHOLIPID TRANSFER PROTEIN; SODIUM CHLORIDE; TRIACYLGLYCEROL;

ADULT; ARTICLE; CONTROLLED STUDY; GLUCOSE CLAMP TECHNIQUE; HUMAN; HUMAN EXPERIMENT; HYPERGLYCEMIA; HYPERINSULINEMIA; LIPID TRANSPORT; MALE; NORMAL HUMAN; PRIORITY JOURNAL;

EID: 0030941885     PISSN: 00365513     EISSN: None     Source Type: Journal    
DOI: 10.1080/00365519709056383     Document Type: Article

References (44)

1. Durrington PN. Hyperlipidemia. Diagnosis and Management. 2nd ed Oxford: Butterworth Heinemann, 1995.
2. Eisenberg S. High density lipoprotein metabolism. J Lipid Res 1984; 25: 1017-58.
3. Dullaart RPF, Groener JEM, Erkelens DW. Cholesterylester transfer between lipoproteins. Diab Nutr Metab 1991; 4: 329-43.
4. Tall AR. Plasma cholesteryl ester transfer protein. J Lipid Res 1993; 34: 1255-74.
5. Lagrost L. Regulation of cholesteryl ester transfer protein (CETP) activity: review of in vitro and in vivo studies. Biochim Biophys Acta 1994; 1215: 209-36.
6. Tall AR, Krumholz S, Olivecrona T, Deckelbaum RJ. Plasma phospholipid transfer protein enhances transfer and exchange of phospholipids between very low density lipoproteins and high density lipoprotein during lipolysis. J Lipid Res 1985; 26: 842-51.
7. Tollefson JH, Ravnik S, Albers JJ. Isolation and characterization of a phospholipid transfer protein (LTP II) from human plasma. J Lipid Res 1988; 29: 1593-1602.
8. Speijer H, Groener JE, van Ramshorst E, Van Tol A. Different locations of cholesteryl ester transfer protein and phospholipid transfer protein activities in plasma. Atherosclerosis 1991; 90: 159-68.
9. Albers JJ, Wolfbauer G, Chueng MC, Day JR, Ching AFT, Lok S, et al. Functional expression of human and mouse plasma phospholipid transfer protein: effect of recombinant and plasma PLTP on HDL subspecies. Biochim Biophys Acta 1995; 1258: 27-34.
10. Jauhiainen M, Metso J, Pahlman R, Blomqvist S, Van Tol A, Ehnholm C. Human plasma phospholipid transfer protein causes high density lipoprotein conversion. J Biol Chem 1993; 268: 4032-36.
11. Tu A, Nishida HI, Nishida T. High density lipoprotein conversion mediated by human plasma phospholipid transfer protein. J Biol Chem 1993; 268: 23098-105.
12. McPherson R, Mann CJ, Tall AR, Hogue M, Martin L, Milne R, et al. Plasma concentrations of cholesteryl ester transfer protein in hyperlipoproteinemia. Arterioscl Thromb 1991; 11: 797-804.
13. Zhao S, Smelt AHM, Van den Maagdenberg AMJM, et al. Plasma lipoprotein profiles of normocholesterolemic homozygotes for Apolipoprotein E2(Arg158XCys) compared. Clin Chem 1994; 40: 1559-66.
14. Dullaart RPF, Gansevoort RT, Dikkeschei LD, de Zeeuw D, de Jong PE, Van Tol A. Role of elevated lecithin: cholesterol acyltransferase and cholesteryl ester transfer protein activities in abnormal lipoproteins from proteinuric patients. Kidney Int 1993; 44: 91-7.
15. Dullaart RPF, Groener JE, Dikkeschei LD, Erkelens DW, Doorenbos H. Increased cholesterylester transfer activity in complicated type 1 (insulin-dependent) diabetes mellitus-its relationship with serum lipids. Diabetologia 1989; 32: 14-9.
16. Dullaart RPF, Sluiter WJ, Dikkeschei LD, Hoogenberg K, Van Tol A. Effect of adiposity on plasma lipid transfer protein activities: a possible link between insulin resistance and high density lipoprotein metabolism. Eur J Clin Invest 1994; 24: 188-94.
17. Arai T, Yamashita S, Hirano K, et al. Increased plasma cholesteryl ester transfer protein in obese subjects. Arterioscler Thromb 1994; 14: 1129-36.
18. Dullaart RPF, Hoogenberg K, Dikkeschei LD, Van Tol A. Higher plasma lipid transfer protein activities and unfavorable lipoprotein changes in cigarette-smoking men. Arterioscler Thromb 1994; 14: 1581-5.
19. Yki-Jarvinen H, Taskinen MR, Nikkila EA. Response of adipose tissue lipoprotein lipase activity and serum lipoproteins to acute hyperinsulinaemia in man. Diabetologia 1984; 27: 364-9.
20. Lewis GF, Uffelman KD, Szeto LW, Steiner G. Effects of acute hyperinsulinaemia on VLDL triglyceride and VLDL apoB production in normal weight and obese individuals. Diabetes 1993; 42: 833-42.
21. Arrol S, Mackness MI, Laing I, Durrington PN. Effects of insulin and glucagon on the secretion of apolipoprotein B-containing lipoproteins and triacylglycerol synthesis by human hepatoma (Hep G2) cells. Diab Nutr Metab 1994; 7: 263-71.
22. Lewis GF, Uffelman KD, Szeto AW, Weller B, Steiner G. Interaction between free fatty acids and insulin in the acute control of very low density lipoprotein production in humans. J Clin Invest 1995; 95: 158-66.
23. Sutherland WHF, Walker RJ, Lewis-Barned NJ, Pratt H, Tillman HC. The effect of acute hyperinsulinemia on plasma cholesteryl ester transfer protein activity in patients with non-insulin-dependent diabetes mellitus and healthy subjects. Metabolism 1994; 43: 1362-6.
24. DeFronzo RA, Tobin JD, Andres R. Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol 1979; 237: E214-23.
25. Van Haeften TW, Boonstra E, Veneman TF, Gerich JE, Van der Veen EA. Dose-response characteristics for glucose-stimulated insulin release in man and the assessment of influence of glucose on arginine stimulated insulin release. Metabolism 1990; 39: 1292-9.
26. Mitrakou A, Vuorinen-Markkola H, Raptis G, et al. Simultaneous assessment of insulin secretion and insulin sensitivity using a hyperglycemic clamp. J Clin Endocrinol Metab 1992; 75: 379-82.
27. Groener JE, Pelton RW, Kostner GM. Improved estimation of cholesteryl ester transfer/exchange activity in serum or plasma. Clin Chem 1986; 32: 283-86.
28. Hannuksela M, Marcel YL, Kesaniemi YA, Savolainen MJ. Reduction in the concentration and activity of plasma cholesteryl ester transfer protein by alcohol. J Lipid Res 1992; 33: 737-44.
29. Groener JEM, Da Col PG, Kostner GM. A hyperalphalipoproteinemic family with normal cholesteryl ester transfer/exchange activity. Biochem J 1987; 242: 27-32.
30. Laakso M, Sarlund H, Mykkanen L. Insulin resistance is associated with lipid and lipoprotein abnormalities in subjects with varying degrees of glucose tolerance. Arterioscler Thromb 1990; 10: 223-31.
31. DeFronzo RA, Ferrannini E. Insulin resistance. A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease. Diabetes Care 1991; 14: 173-94.
32. Facchini FS, Hollenbeck CB, Jeppesen J, Chen YD, Reaven GM. Insulin resistance and cigarette smoking. Lancet 1992; 339: 1128-30.
33. Elcheby M, Pulcini T, Porokhov B, Berthezene F, Ponsin G. Multiple abnormalities in the transfer of phospholipids from VLDL and LDL to HDL in non-insulin-dependent diabetes. Eur J Clin Invest 1996; 26: 216-23.
34. Reaven GM, Laws A. Insulin resistance, compensatory hyperinsulinemia, and coronary heart disease. Diabetologia 1994; 37: 948-52.
35. Lusa S, Jauhiainen M, Metso J, Somerharju P, Ehnholm C. The mechanism of human plasma phospholipid transfer protein-induced enlargement of high-density lipoprotein particles: evidence for particle fusion. Biochem J 1996; 313: 275-82.
36. Fielding CJ, Fielding PE. Molecular physiology of reverse cholesterol transport [review]. J Lipid Res 1995; 36: 211-28.
37. Von Eckardstein A, Jauhiainen M, Huang Y, et al. Phospholipid transfer protein mediated conversion of high density lipoproteins generates preβ-HDL. Biochim Biophys Acta 1996; 1301: 255-262.
38. Jiang X-C, Bruce C. Regulation of murine plasma phospholipid transfer protein activity and mRNA levels by lipopolysaccharide and high cholesterol diet. J Biol Chem 1995; 270: 17133-8.
39. Lagrost L, Florentin E, Guyard-Dangremont V, Athias A, Gandjini H, Lallemant C, et al. Evidence for nonesterified fatty acids as modulators of neutral lipid transfers in normolipidemic human plasma. Arterioscler Thromb Vasc Biol 1995; 15: 1388-96.
40. Barter PJ, Chang LBF, Rajaram OV. Sodium oleate promotes a redistribution of cholesteryl esters from high to low density lipoproteins. Atherosclerosis 1990; 84: 13-24.
41. Lagrost L, Barter PJ. Effects of various nonesterified fatty acids on the transfer of cholesteryl esters from HDL to LDL induced by the cholesteryl ester transfer protein. Biochim Biophys Acta 1991; 1085: 209-216.
42. Barter PJ, Chang LBF, Newham HH, Rye K-A, Rajaram OV. The interaction of cholesteryl ester transfer and unesterified fatty acids promotes a reduction in the particle size of high-density lipoproteins. Biochim Biophys Acta 1990; 1045: 81-89.
43. Austin MA. Plasma triglycerides as a risk factor for coronary heart disease: epidemiologic evidence and beyond. Amer J Epidemiol 1989; 129: 249-59.
44. Mann CJ, Yen FT, Grant AM, Bihain BE. Mechanism of plasma cholesteryl ester transfer in hypertriglyceridemia. J Clin Invest 1991; 88: 2059-66.